Current rates of prosthetic usage in upper-limb amputees - have innovations had an impact on device acceptance?


Journal

Disability and rehabilitation
ISSN: 1464-5165
Titre abrégé: Disabil Rehabil
Pays: England
ID NLM: 9207179

Informations de publication

Date de publication:
07 2022
Historique:
pubmed: 31 12 2020
medline: 16 7 2022
entrez: 30 12 2020
Statut: ppublish

Résumé

There is a large body of evidence demonstrating high rates of prosthesis abandonment in the upper extremity. However, these surveys were conducted years ago, thus the influence of recent refinements in prosthetic technology on acceptance is unknown. This study aims to gather current data on prosthetic usage, to assess the effects of these advancements. A questionnaire was sent to 68 traumatic upper limb amputees treated within the Austrian Trauma Insurance Agency between the years 1996 and 2016. Responses were grouped by the year of amputation to assess the effect of time. The rejection rate at all levels of amputation was 44%. There was no significant difference in acceptance between responders amputated before or after 2006 ( The advancements of the last decade in the arena of upper limb prosthetics have not yet achieved a significant change in prosthetic abandonment within this study cohort. Although academic solutions have been presented to tackle patient's complaints, clinical reality still shows high rejection rates of cost-intensive prosthetic devices.Implications for rehabilitationAbandonment rates in prosthetic rehabilitation after upper limb amputation have shown to be 50% and higher.The advancements of the last decade in the arena of upper limb prosthetics have not yet achieved a significant change in prosthetic abandonment.Well-structured and patient-tailored prosthetic training as well as ensuring the amputee's active participation in the decision making process will most likely improve prosthetic acceptance.

Identifiants

pubmed: 33377803
doi: 10.1080/09638288.2020.1866684
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3708-3713

Auteurs

Stefan Salminger (S)

Department of Surgery, Division of Plastic and Reconstructive Surgery, Medical University of Vienna, Vienna, Austria.
Clinical Laboratory for Bionic Extremity Reconstruction, Medical University of Vienna, Vienna, Austria.

Heiko Stino (H)

Clinical Laboratory for Bionic Extremity Reconstruction, Medical University of Vienna, Vienna, Austria.

Lukas H Pichler (LH)

AUVA Trauma Center Linz, Linz, Austria.

Clemens Gstoettner (C)

Clinical Laboratory for Bionic Extremity Reconstruction, Medical University of Vienna, Vienna, Austria.

Agnes Sturma (A)

Clinical Laboratory for Bionic Extremity Reconstruction, Medical University of Vienna, Vienna, Austria.
Department of Bioengineering, Imperial College London, London, UK.

Johannes A Mayer (JA)

Clinical Laboratory for Bionic Extremity Reconstruction, Medical University of Vienna, Vienna, Austria.

Michael Szivak (M)

Department of Medical Documentation and Statistics, Austrian Trauma Insurance Agency (AUVA), Vienna, Austria.

Oskar C Aszmann (OC)

Department of Surgery, Division of Plastic and Reconstructive Surgery, Medical University of Vienna, Vienna, Austria.
Clinical Laboratory for Bionic Extremity Reconstruction, Medical University of Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH